EMOSIS promises a major change in diagnosing hemostasis disorders.
We have developed a series of simple-to-operate, high performance test kits. Each one uses a dedicated menu-driven benchtop flow cytometer to simply, quickly and accurately test for a broad range of hemostasis disorders.
CONFIRMING or disaffirming the suspicion of a hemostasis disturbance is essential in patient-focused best clinical practice.
Every year, millions of patients across all medical specialties are suspected of having a pathophysiological or drug-induced hemostasis disorders, which can prove disabling, or even fatal, if left untreated. Conversely, suspected cases that are later found to be normal may have been subjected to unnecessary treatment.
EMOSIS has assembled a high-performing team of specialists with a wealth of experience in myriad scientific, medical, industrial and business disciplines.
The range of skills brought by the members of this multinational, multidisciplinary team fully support our goal of fulfilling a pressing need felt by all practitioners involved in the care of patients with a suspected hemostasis disorder.
Real-time in vivo thrombus formation (mouse model).
Injury immediately induces a series of events that, within 60 seconds, culminate in the development of a fibrin plug at the site of injury.